A 42-year-old man with a family history of multiple endocrine neoplasia type 2A (MEN 2A) is found to have bilateral adrenal masses on imaging. Plasma free metanephrines are markedly elevated. Which biochemical or imaging feature best distinguishes bilateral pheochromocytoma (as in MEN 2A) from a solitary pheochromocytoma with an incidental contralateral adrenal adenoma?

Explanation

## Bilateral vs. Solitary Pheochromocytoma: Biochemical Discrimination ### The Core Distinction **Key Point:** In bilateral pheochromocytoma, **both adrenal glands are secreting excess catecholamines**, resulting in markedly elevated plasma free metanephrines and catecholamines from BOTH sources. In contrast, a solitary pheochromocytoma with an incidental contralateral adenoma shows biochemical evidence of hormone excess from only ONE gland. ### Pathophysiology **High-Yield:** Bilateral pheochromocytomas occur in ~5–10% of all pheochromocytomas but in **30–50% of MEN 2A patients**. The bilateral nature means catecholamine production is doubled, leading to more severe biochemical abnormalities. ### Comparison Table | Feature | Bilateral Pheochromocytoma (MEN 2A) | Solitary Pheo + Incidental Adenoma | | --- | --- | --- | | **Plasma Free Metanephrines** | Markedly elevated (both glands contribute) | Elevated (one gland only) | | **Plasma Catecholamines** | Very high (additive from both medullae) | Moderately high | | **24-h Urine Metanephrines** | Markedly elevated | Mildly to moderately elevated | | **Imaging: Bilateral Masses** | Both are functional pheochromocytomas | One is pheo; other is non-functional adenoma | | **Biochemical Symmetry** | Hormone levels reflect dual secretion | Asymmetric (one side drives excess) | | **Clinical Severity** | More severe hypertension, symptoms | Variable; depends on solitary pheo size | | **Associated Features** | Medullary thyroid cancer, hyperparathyroidism (MEN 2A) | No syndromic features | ### Why Imaging Alone Is Insufficient **Clinical Pearl:** Bilateral adrenal masses on CT/MRI do NOT automatically mean bilateral pheochromocytoma. The contralateral mass may be a non-functional adenoma (common incidental finding). **Biochemical testing from both glands (via selective adrenal venous sampling if needed) or markedly elevated systemic catecholamine levels** is required to confirm bilateral functional disease. ### Biochemical Confirmation Strategy 1. **Plasma free metanephrines:** If markedly elevated (often >4× upper limit of normal in bilateral disease), suggests dual secretion. 2. **24-hour urine metanephrines:** Proportionally higher in bilateral disease. 3. **Selective adrenal venous sampling (AVS):** Gold standard if imaging is ambiguous — shows elevated catecholamines from BOTH adrenal veins in bilateral disease. ### Mnemonic **BILATERAL = Both glands Increase Levels, Additive Toxicity, Elevated catecholamines Twice** — biochemical evidence of dual secretion is the discriminator. [cite:Harrison 21e Ch 405; Robbins 10e Ch 24]